What is the association between lymphadenectomy and survival, disease recurrence, and surgical morbidity in women with presumed early-stage, low-grade endometrial carcinoma?
The evidence from randomized clinical trials suggests that lymphadenectomy does not improve survival or decrease disease recurrence in women with early-stage, low-grade endometrial carcinoma. Furthermore lymphadenectomy is associated with an increase in both short- and long-term surgery-related systemic morbidity.
Frost JA, Webster KE, Morrison J. Lymphadenectomy for Treatment of Early-Stage Endometrial Cancer. JAMA Oncol. 2017;3(1):117–118. doi:10.1001/jamaoncol.2016.4873
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.